Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $82.20 ($543K) on 2016-11-30, disclosed to the SEC on 2016-12-02.
Scheduled sale ($543k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.20 | 2,200 | $181K | 33.3% |
| 2 | $83.48 | 2,100 | $175K | 32.3% |
| 3 | $84.53 | 1,700 | $144K | 26.5% |
| 4 | $85.53 | 500 | $43K | 7.9% |
| Total | $83.48 avg | 6,500 | $543K | 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |